Moved by
Lord Patel
27: Clause 2, page 2, line 35, at end insert—
“( ) Regulations under section 1(1) must make provision to enable the Medicines and Healthcare products Regulatory Agency to work with other regulators to minimise delay for the United Kingdom to get early access to new medicines.”